BACKGROUND: Several studies have shown that inactivated, whole-cell oral cholera vaccines (OCVs) confer both direct protection on vaccinees and herd protection on populations. Because our earlier cluster-randomized effectiveness trial (CRT) in urban Bangladesh failed to detect OCV herd protection, we reanalysed the trial to assess whether herd effects were masked in our original analysis. METHODS: A total of 267 270 persons were randomized to 90 approximately equal-sized clusters. In 60 clusters persons aged 1 year and older were eligible to receive OCV and in 30 clusters persons received no intervention and served as controls. We analysed OCV protection against severely dehydrating cholera for the entire clusters, as in our original analys...
Background: Oral cholera vaccines represent a new effective tool to fight cholera and are licensed a...
Analyses of stool from patients with acute watery diarrhea (AWD) using sensitive molecular diagnosti...
Background Vaccine herd protection assessed in a cluster-randomized trial (CRT) may be masked by di...
Recent analysis of results of the 1985 vaccine trial in Bangladesh showed that a killed oral cholera...
BACKGROUND: Decisions about the use of killed oral cholera vaccines, which confer moderate levels of...
BACKGROUND: In a cluster randomized trial (CRT) of a Vi polysaccharide vaccine against typhoid in th...
BACKGROUND: Cholera is known to be transmitted from person to person, and inactivated oral cholera v...
<div><p>Background</p><p>Oral cholera vaccination is an approach to preventing outbreaks in at-risk ...
Background Cholera is endemic in Bangladesh with epidemics occurring each year. The decision to use ...
Oral cholera vaccination is an approach to preventing outbreaks in at-risk settings and controlling ...
BACKGROUND: Killed whole-cell oral cholera vaccines (kOCVs) are becoming a standard cholera control ...
Traditional vaccine trial methods have an underlying assumption that the effect of a vaccine is the ...
Background A single-dose regimen of inactivated whole-cell oral cholera vaccine (OCV) is attractive ...
Traditional vaccine trial methods have an underlying assumption that the effect of a vaccine is the ...
Background: Oral cholera vaccines consisting of killed whole cells have been available for many ...
Background: Oral cholera vaccines represent a new effective tool to fight cholera and are licensed a...
Analyses of stool from patients with acute watery diarrhea (AWD) using sensitive molecular diagnosti...
Background Vaccine herd protection assessed in a cluster-randomized trial (CRT) may be masked by di...
Recent analysis of results of the 1985 vaccine trial in Bangladesh showed that a killed oral cholera...
BACKGROUND: Decisions about the use of killed oral cholera vaccines, which confer moderate levels of...
BACKGROUND: In a cluster randomized trial (CRT) of a Vi polysaccharide vaccine against typhoid in th...
BACKGROUND: Cholera is known to be transmitted from person to person, and inactivated oral cholera v...
<div><p>Background</p><p>Oral cholera vaccination is an approach to preventing outbreaks in at-risk ...
Background Cholera is endemic in Bangladesh with epidemics occurring each year. The decision to use ...
Oral cholera vaccination is an approach to preventing outbreaks in at-risk settings and controlling ...
BACKGROUND: Killed whole-cell oral cholera vaccines (kOCVs) are becoming a standard cholera control ...
Traditional vaccine trial methods have an underlying assumption that the effect of a vaccine is the ...
Background A single-dose regimen of inactivated whole-cell oral cholera vaccine (OCV) is attractive ...
Traditional vaccine trial methods have an underlying assumption that the effect of a vaccine is the ...
Background: Oral cholera vaccines consisting of killed whole cells have been available for many ...
Background: Oral cholera vaccines represent a new effective tool to fight cholera and are licensed a...
Analyses of stool from patients with acute watery diarrhea (AWD) using sensitive molecular diagnosti...
Background Vaccine herd protection assessed in a cluster-randomized trial (CRT) may be masked by di...